BridgeBio Oncology Therapeutics Inc.
BBOT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$45 | -$28 | -$0 | $2 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1 | $0 | $0 |
| Change in WC | $10 | $4 | $0 | $0 |
| Other Non-Cash | -$37 | -$0 | -$0 | -$2 |
| Operating Cash Flow | -$71 | -$23 | -$1 | -$0 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$63 | -$34 | $0 | $0 |
| Inv. Sales/Matur. | $129 | $44 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $66 | $10 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $373 | $0 | $0 | $0 |
| Stock Issued | $22 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$12 | $19 | $0 | $187 |
| Financing Cash Flow | $384 | $19 | $0 | $0 |
| Forex Effect | $29 | $0 | $0 | $0 |
| Net Chg. in Cash | $408 | $5 | -$1 | -$0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1 | $26 | $2 | $2 |
| End Cash | $409 | $32 | $1 | $2 |
| Free Cash Flow | -$71 | -$24 | -$1 | -$0 |